NEW YORK, Sept. 20, 2005 (PRIMEZONE) -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Knoxville, TN-based Provectus Pharmaceuticals, Inc. (OTCBB:PVCT). The full 44-page report can be found at www.crystalra.com, or through a link located in the Investor Relations section of the Provectus web site at www.pvct.com. This report was paid for by Provectus Pharmaceuticals, Inc.
Provectus Pharmaceuticals, Inc. is a pioneering pharmaceutical company actively engaged in the design, development, and marketing of pharmaceutical technologies for the treatment of breast cancer, liver cancer, and metastatic melanoma. In addition, Provectus is preparing to begin Phase II clinical studies for the Company's topical agent Xantryl(TM), a treatment for psoriasis.
The Company's lead cancer agent Provecta(TM) (PV-10) is in its first Phase 1 clinical trial and is being evaluated for safety and preliminary efficacy in 20 subjects with Stage III metastatic melanoma, which is the most aggressive form of skin cancer. The study is being conducted at two of the world's leading melanoma treatment and research centers, both located in New South Wales, Australia -- a country where the incidence of melanoma is more than twice that of the United States
About Crystal Research Associates, LLC
Crystal Research Associates, LLC is an independent research firm that provides institutional-quality fee-based research to small and mid-cap companies. The Company's unique and novel product, the Executive Informational Overview(R) (EIO(R)), is free of investment ratings, target prices, and forward-looking financial models. The EIO(R) presents a crystal-clear, detailed report on a company (whether public or private) in a manner that is easily understood by the Wall Street financial community. The EIO(R) details a company's product/technology/service offerings, market size(s), key intellectual property (IP), leadership, growth strategy, competition, risks, audited financial statements, key events and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto. Please see back of report for complete Company disclosures.